Vendor review
LSPL reviews
LSPL reviews from 57 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is LSPL legit? See what its vials showed.
What the lab tests show
57 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 8, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 46.4 mg of 40 mg (16 %) | Pass | View |
| Jul 14, 2026 | Tirzepatide | 99.9 % | 27 mg of 30 mg (-10 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.7 % | 22.8 mg of 20 mg (14 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 18.6 mg of 20 mg (-7 %) | Pass | View |
| Jun 2, 2026 | Tirzepatide | 99.8 % | 28.7 mg of 30 mg (-4 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 27.1 mg of 30 mg (-10 %) | Pass | View |
| May 5, 2026 | Tirzepatide | 99.9 % | 29.8 mg of 30 mg (-1 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.3 % | 47.6 mg of 40 mg (19 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 41.9 mg of 40 mg (5 %) | Pass | View |
| Mar 4, 2026 | Ipamorelin | 99.9 % | 10 mg of 10 mg (0 %) | Pass | View |
| Feb 22, 2026 | GHK-Cu | 99.9 % | 62.4 mg of 50 mg (25 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.87 % | 8.25 mg of 10 mg (-18 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.9 % | 17.1 mg of 10 mg (71 %) | Pass | View |
| Feb 20, 2026 | Cagrilintide | 99.9 % | 4.75 mg of 5 mg (-5 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.32 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Feb 18, 2026 | GHK-Cu | 99.9 % | 47.2 mg of 50 mg (-6 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.59 % | 19.1 mg of 20 mg (-4 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 98.72 % | 6.01 mg of 10 mg (-40 %) | Pass | View |
| Jan 19, 2026 | Tirzepatide | 99.95 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 98.45 % | 44.7 mg of 40 mg (12 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.15 % | 41 mg of 40 mg (2 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.5 % | 5.4 mg of 5 mg (8 %) | Pass | View |
| Jan 1, 2026 | Ipamorelin | 99.2 % | 4.4 mg of 5 mg (-12 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.6 % | 32.7 mg of 30 mg (9 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.6 % | 33 mg of 30 mg (10 %) | Pass | View |
| Dec 22, 2025 | Tirzepatide | 99.77 % | 32.5 mg of 40 mg (-19 %) | Pass | View |
| Dec 22, 2025 | Tirzepatide | 99.95 % | 65.6 mg of 60 mg (9 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.8 % | 34.1 mg of 20 mg (71 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.6 % | 25.4 mg of 30 mg (-15 %) | Pass | View |
| Dec 13, 2025 | Retatrutide | 99.4 % | 33.7 mg of 30 mg (12 %) | Pass | View |
| Dec 13, 2025 | Retatrutide | 99.5 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| Dec 11, 2025 | Retatrutide | 62.38 % | 7.83 mg of 10 mg (-22 %) | Pass | View |
| Dec 11, 2025 | GHK-Cu | 99.86 % | 46.7 mg of 50 mg (-7 %) | Pass | View |
| Dec 11, 2025 | Cagrilintide | 99.91 % | 5 mg of 5 mg (0 %) | Pass | View |
| Dec 10, 2025 | Retatrutide | 98.2 % | 5.5 mg of 5 mg (10 %) | Pass | View |
| Dec 10, 2025 | Retatrutide | 99.6 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Dec 6, 2025 | GHK-Cu | 99.95 % | 103 mg of 100 mg (3 %) | Pass | View |
| Dec 6, 2025 | GHK-Cu | 99.88 % | 140 mg of 100 mg (40 %) | Pass | View |
| Dec 4, 2025 | Retatrutide | 99.95 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Dec 2, 2025 | Retatrutide | 99.5 % | 16.5 mg of 20 mg (-18 %) | Pass | View |
| Nov 23, 2025 | Retatrutide | 99.9 % | 35.2 mg of 20 mg (76 %) | Pass | View |
| Nov 23, 2025 | Tirzepatide | 99.7 % | 22.5 mg of 20 mg (13 %) | Pass | View |
| Nov 23, 2025 | Tirzepatide | 99.5 % | 11.63 mg of 10 mg (16 %) | Pass | View |
| Nov 23, 2025 | Retatrutide | 99.8 % | 16.8 mg of 20 mg (-16 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 98.2 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 98.39 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Nov 6, 2025 | Tirzepatide | 99.4 % | 9.6 mg of 10 mg (-4 %) | Pass | View |
| Nov 6, 2025 | Retatrutide | 99.95 % | 9.79 mg of 10 mg (-2 %) | Pass | View |
| Nov 6, 2025 | GHK-Cu | 99.91 % | 49.5 mg of 50 mg (-1 %) | Pass | View |
| Sep 4, 2025 | Cagrilintide | 99.68 % | 9.35 mg of 10 mg (-7 %) | Pass | View |
| Aug 5, 2025 | Tirzepatide | 99.69 % | 27.9 mg of 30 mg (-7 %) | Pass | View |
| Aug 5, 2025 | Tirzepatide | 99.95 % | 38.2 mg of 40 mg (-4 %) | Pass | View |
| Aug 3, 2025 | Tirzepatide | 99.115 % | 11.19 mg of 10 mg (12 %) | Pass | View |
| Jun 11, 2025 | Tirzepatide | 99.86 % | 9.22 mg of 10 mg (-8 %) | Pass | View |
| Jun 10, 2025 | Ipamorelin | 99.97 % | 4.46 mg of 5 mg (-11 %) | Pass | View |
What LSPL sells
No current listings on record.
About LSPL
Just Found A facebook page